46
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES Clinical Translational Therapeutics

Chromosome 3p Microsatellite Allelotyping in Neuroblastoma: A Report on the Technical Hurdles

, , , , , , , , , , , & show all
Pages 857-868 | Published online: 01 Sep 2009

REFERENCES

  • Breen C. J., O'Meara A., McDermott M., et al. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 2000; 120: 44–49
  • Luttikhuis M. E., Powell J. E., Rees S. A., et al. Neuroblastomas with chromosome 11q loss and single-copy MYCN comprise a biologically distinct group of tumours with adverse prognosis. Br J Cancer 2001; 85: 531–537
  • Plantaz D., Vandesompele J., Van Roy N., et al. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer 2001; 91: 680–686
  • Vandesompele J., Speleman F., Van Roy N., et al. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?. Med Pediatr Oncol 2001; 36: 5–10
  • Vandesompele J., Van Roy N., Van Gele M., et al. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 1998; 23: 141–152
  • Vandesompele J., Baudis M., De Preter K., et al. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. J Clin Oncol 2005; 23: 2280–2299
  • Hoebeeck J., Michels E., Menten B., et al. High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21–p22 tumor suppressor genes in neuroblastoma and more frequent tumors. Int J Cancer 2007; 120: 533–538
  • Brodeur G. M., Pritchard J., Berthold F., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466–1477
  • Van Gele M., Van Roy N., Jauch A., et al. Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis. Eur J Cancer 1997; 33: 1979–1982
  • Van Roy N., Jauch A., Van Gele M., et al. Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines. Cancer Genet Cytogenet 1997; 97: 135–142
  • Van Roy N., Van Limbergen H., Vandesompele J., et al. Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines. Genes Chromosomes Cancer 2001; 32: 126–135
  • Devilee P., Cleton-Jansen A. M., Cornelisse C. J. Ever since Knudson. Trends Genet 2001; 17: 569–573
  • Goldberg E. K., Glendening J. M., Karanjawala Z., et al. Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis. Am J Hum Genet 2000; 67: 417–431
  • Menten B., Buysse K., Vandesompele J., et al. Identification of an unbalanced X-autosome translocation by array CGH in a boy with a syndromic form of chondrodysplasia punctata brachytelephalangic type. Eur J Med Genet 2005; 48: 301–309
  • Menten B., Pattyn F., De Preter K., et al. Arraycghbase: an analysis platform for comparative genomic hybridization microarrays. BMC Bioinformatics 2005; 6: 124
  • Anderson M., Stanbridge E. Microcell-mediated chromosome transfer: selective transfer and retention of single human chromosomes into recipient cells of choice. Cell Biology: A Laboratory Handbook, J. Celis. Academic Press, Inc., New York 1994; 428–433
  • Shinde D., Lai Y., Sun F., et al. Taq DNA polymerase slippage mutation rates measured by PCR and quasi-likelihood analysis: (CA/GT)n and (A/T)n microsatellites. Nucleic Acids Res 2003; 31: 974–980
  • Odelberg S. J., White R. A method for accurate amplification of polymorphic CA-repeat sequences. PCR Methods Appl 1993; 3: 7–12
  • Miller M. J., Yuan B. Z. Semiautomated resolution of overlapping stutter patterns in genomic microsatellite analysis. Anal Biochem 1997; 251: 50–56
  • Liu J., Zabarovska V. I., Braga E., et al. Loss of heterozygosity in tumor cells requires re-evaluation: the data are biased by the size-dependent differential sensitivity of allele detection. FEBS Lett 1999; 462: 121–128
  • Michels E., Vandesompele J., Hoebeeck J., et al. Genome wide measurement of DNA copy number changes in neuroblastoma: dissecting amplicons and mapping losses, gains, and breakpoints. Cytogenet Genome Res 2006; 115: 273–282
  • Caren H., Erichsen J., Olsson L., et al. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene. BMC Genomics 2008; 9: 353
  • Bader S. A., Fasching C., Brodeur G. M., et al. Dissociation of suppression of tumorigenicity and differentiation in vitroeffected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 1991; 2: 245–255

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.